Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "ANDA"

3099 News Found

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026
Policy | June 12, 2026

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026

Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance


Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation


Narayana Health achieves HIMSS AMAM Stage 6, first in Indian subcontinent
Hospitals | June 12, 2026

Narayana Health achieves HIMSS AMAM Stage 6, first in Indian subcontinent

Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.


Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
People | June 11, 2026

Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager

Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions


Evonik unveils probiotic advance in fight against antibiotic resistance
R&D | June 11, 2026

Evonik unveils probiotic advance in fight against antibiotic resistance

Evonik researchers say they have achieved a significant breakthrough with Ecobiol


Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
News | June 11, 2026

Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access

The Prayagraj lab is designed to handle both routine and specialised testing


Dr. Alka Rao becomes first woman director of CSIR-IMTECH
People | June 11, 2026

Dr. Alka Rao becomes first woman director of CSIR-IMTECH

Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI


Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
Drug Approval | June 11, 2026

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules

Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.


AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Drug Approval | June 11, 2026

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio